These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19265161)

  • 21. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelium and immune responses: implications for inflammation and angiogenesis.
    Szekanecz Z; Koch AE
    Rheum Dis Clin North Am; 2004 Feb; 30(1):97-114. PubMed ID: 15061570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4).
    Fierro IM; Kutok JL; Serhan CN
    J Pharmacol Exp Ther; 2002 Feb; 300(2):385-92. PubMed ID: 11805195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chitosan particles and dexamethasone on human bone marrow stromal cell osteogenesis and angiogenic factor secretion.
    Guzmán-Morales J; El-Gabalawy H; Pham MH; Tran-Khanh N; McKee MD; Wu W; Centola M; Hoemann CD
    Bone; 2009 Oct; 45(4):617-26. PubMed ID: 19540373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
    Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
    Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoxin A4 counterregulates GM-CSF signaling in eosinophilic granulocytes.
    Starosta V; Pazdrak K; Boldogh I; Svider T; Kurosky A
    J Immunol; 2008 Dec; 181(12):8688-99. PubMed ID: 19050289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of lipoxin in the modulation of immune response during infection.
    Machado FS; Aliberti J
    Int Immunopharmacol; 2008 Oct; 8(10):1316-9. PubMed ID: 18687293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects.
    Detoraki A; Staiano RI; Granata F; Giannattasio G; Prevete N; de Paulis A; Ribatti D; Genovese A; Triggiani M; Marone G
    J Allergy Clin Immunol; 2009 May; 123(5):1142-9, 1149.e1-5. PubMed ID: 19275959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation.
    Hashimoto A; Murakami Y; Kitasato H; Hayashi I; Endo H
    Biomed Pharmacother; 2007 Jan; 61(1):81-5. PubMed ID: 17184966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors.
    Forsman H; Dahlgren C
    Scand J Immunol; 2009 Oct; 70(4):396-402. PubMed ID: 19751275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and anti-inflammatory effect of lipoxins in human airway epithelial cells.
    Bonnans C; Gras D; Chavis C; Mainprice B; Vachier I; Godard P; Chanez P
    Biomed Pharmacother; 2007 Jun; 61(5):261-7. PubMed ID: 17418999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF.
    Kim WH; Lee SH; Jung MH; Seo JH; Kim J; Kim MA; Lee YM
    Exp Cell Res; 2009 Aug; 315(13):2154-64. PubMed ID: 19409892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis.
    Kim GY; Lee JW; Cho SH; Seo JM; Kim JH
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):915-20. PubMed ID: 19286633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG; Khreiss T; József L
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):257-62. PubMed ID: 15979865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment.
    Hao H; Liu M; Wu P; Cai L; Tang K; Yi P; Li Y; Chen Y; Ye D
    Cancer Lett; 2011 Oct; 309(1):85-94. PubMed ID: 21683517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
    Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N; Arita M; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiangiogenic properties of silver nanoparticles.
    Gurunathan S; Lee KJ; Kalishwaralal K; Sheikpranbabu S; Vaidyanathan R; Eom SH
    Biomaterials; 2009 Oct; 30(31):6341-50. PubMed ID: 19698986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoxins: update and impact of endogenous pro-resolution lipid mediators.
    O'Meara SJ; Rodgers K; Godson C
    Rev Physiol Biochem Pharmacol; 2008; 160():47-70. PubMed ID: 18481030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.